Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers

Journal of Proteome Research

Volumn 11, Issue 4, 2012, Pages 2508-2520

  Drake, Penelope M ^a   Schilling, Birgit ^b   Niles, Richard K ^a   Prakobphol, Akraporn ^a   Li, Bensheng ^b   Jung, Kwanyoung ^c   Cho, Wonryeon ^d   Braten, Miles ^a   Inerowicz, Halina D ^c   Williams, Katherine ^a   Albertolle, Matthew ^a   Held, Jason M ^b   Iacovides, Demetris ^e   Sorensen, Dylan J ^b   Griffith, Obi L ^e   Johansen, Eric ^a   Zawadzka, Anna M ^b   Cusack, Michael P ^b   Allen, Simon ^a   Gormley, Matthew ^a   Hall, Steven C ^a   Witkowska, H Ewa ^a   Gray, Joe W ^e,f   Regnier, Fred ^c   Gibson, Bradford W ^b,g   Fisher, Susan J ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^c PURDUE UNIVERSITY   (United States)

^d Wonkwang University   (South Korea)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^f Oregon Health and Science University Department of Biomedical Engineering   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AAL; breast cancer; fucose; lectin chromatography; lectins; sialic acid; SNA; triple negative

Indexed keywords

BIOLOGICAL MARKER; FUCOSE; FUCOSYLTRANSFERASE; GLYCOPROTEIN; LECTIN; MESSENGER RNA; PHENOBARBITAL; PLANT LECTIN; SIALIC ACID; SIALYLTRANSFERASE;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME CHEMISTRY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; LECTIN CHROMATOGRAPHY MASS SPECTROMETRY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; RNA SEQUENCE; SAMBUCUS NIGRA; STATISTICAL ANALYSIS; TRIPLE NEGATIVE BREAST CANCER;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; FEMALE; GLYCOPROTEINS; HUMANS; LECTINS; MASS SPECTROMETRY; MEMBRANE PROTEINS; PROTEOME; TUMOR MARKERS, BIOLOGICAL;

ALEURIA AURANTIA; SAMBUCUS NIGRA;

EID: 84859562227     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201206w     Document Type: Article

References (78)

1. Drake, P. M.; Cho, W.; Li, B.; Prakobphol, A.; Johansen, E.; Anderson, N. L.; Regnier, F. E.; Gibson, B. W.; Fisher, S. J. Sweetening the Pot: Adding Glycosylation to the Biomarker Discovery Equation Clin. Chem. 2010, 56, 223-36
2. Hart, G. W.; Copeland, R. J. Glycomics hits the big time Cell 2010, 143 (5) 672-6
3. Clowers, B. H.; Dodds, E. D.; Seipert, R. R.; Lebrilla, C. B. Site determination of protein glycosylation based on digestion with immobilized nonspecific proteases and Fourier transform ion cyclotron resonance mass spectrometry J. Proteome Res. 2007, 6 (10) 4032-40
4. Duffy, M. J.; Evoy, D.; McDermott, E. W. CA 15-3: uses and limitation as a biomarker for breast cancer Clin. Chim. Acta 2010, 411 (23-24) 1869-74
5. Orntoft, T. F.; Vestergaard, E. M. Clinical aspects of altered glycosylation of glycoproteins in cancer Electrophoresis 1999, 20 (2) 362-71
6. Hammarstrom, S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues Semin. Cancer Biol. 1999, 9 (2) 67-81
7. Meany, D. L.; Zhang, Z.; Sokoll, L. J.; Zhang, H.; Chan, D. W. Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns J. Proteome Res. 2009, 8 (2) 613-9
8. Moss, E. L.; Hollingworth, J.; Reynolds, T. M. The role of CA125 in clinical practice J. Clin. Pathol. 2005, 58 (3) 308-12
9. Witz, I. P. The selectin-selectin ligand axis in tumor progression Cancer Metastasis Rev. 2008, 27 (1) 19-30
10. Rosen, S. D. Ligands for L-selectin: homing, inflammation, and beyond Annu. Rev. Immunol. 2004, 22, 129-56
11. Perou, C. M.; Borresen-Dale, A. L. Systems Biology and Genomics of Breast Cancer Cold Spring Harb. Perspect. Biol. 2011, 3 (2, Feb 1) pii: a003293, 10.1101/cshperspect.a003293
12. OBrien, K. M.; Cole, S. R.; Tse, C. K.; Perou, C. M.; Carey, L. A.; Foulkes, W. D.; Dressler, L. G.; Geradts, J.; Millikan, R. C. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study Clin. Cancer Res. 2010, 16 (24) 6100-10
13. Espinosa, E.; Vara, J. A.; Navarro, I. S.; Gamez-Pozo, A.; Pinto, A.; Zamora, P.; Redondo, A.; Feliu, J. Gene profiling in breast cancer: Time to move forward Cancer Treat. Rev. 2011, 37 (6, Oct) 416-21
14. Prat, A.; Parker, J. S.; Karginova, O.; Fan, C.; Livasy, C.; Herschkowitz, J. I.; He, X.; Perou, C. M. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Res. 2010, 12 (5) R68
15. Toft, D. J.; Cryns, V. L. Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies Mol. Endocrinol. 2011, 25 (2) 199-211
16. Abramson, V.; Arteaga, C. L. New strategies in HER2-overexpressing breast cancer: Many combinations of targeted drugs available Clin. Cancer Res. 2011, 17 (5, Mar 1) 952-8
17. McDermott, U.; Settleman, J. Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology J. Clin. Oncol. 2009, 27 (33) 5650-9
18. Yagata, H.; Kajiura, Y.; Yamauchi, H. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy Breast Cancer 2011, 18 (3, Jul) 165-73
19. Pal, S. K.; Childs, B. H.; Pegram, M. Triple negative breast cancer: unmet medical needs Breast Cancer Res. Treat. 2011, 125 (3) 627-36
20. Lapuk, A.; Marr, H.; Jakkula, L.; Pedro, H.; Bhattacharya, S.; Purdom, E.; Hu, Z.; Simpson, K.; Pachter, L.; Durinck, S.; Wang, N.; Parvin, B.; Fontenay, G.; Speed, T.; Garbe, J.; Stampfer, M.; Bayandorian, H.; Dorton, S.; Clark, T. A.; Schweitzer, A.; Wyrobek, A.; Feiler, H.; Spellman, P.; Conboy, J.; Gray, J. W. Exon-level microarray analyses identify alternative splicing programs in breast cancer Mol. Cancer Res. 2010, 8 (7) 961-74
21. Neve, R. M.; Chin, K.; Fridlyand, J.; Yeh, J.; Baehner, F. L.; Fevr, T.; Clark, L.; Bayani, N.; Coppe, J. P.; Tong, F.; Speed, T.; Spellman, P. T.; DeVries, S.; Lapuk, A.; Wang, N. J.; Kuo, W. L.; Stilwell, J. L.; Pinkel, D.; Albertson, D. G.; Waldman, F. M.; McCormick, F.; Dickson, R. B.; Johnson, M. D.; Lippman, M.; Ethier, S.; Gazdar, A.; Gray, J. W. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 2006, 10 (6) 515-27
22. Korkola, J.; Gray, J. W. Breast cancer genomes - form and function Curr. Opin. Genet. Dev. 2010, 20 (1) 4-14
23. Kuo, W. L.; Das, D.; Ziyad, S.; Bhattacharya, S.; Gibb, W. J.; Heiser, L. M.; Sadanandam, A.; Fontenay, G. V.; Hu, Z.; Wang, N. J.; Bayani, N.; Feiler, H. S.; Neve, R. M.; Wyrobek, A. J.; Spellman, P. T.; Marton, L. J.; Gray, J. W. A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047 BMC Med. 2009, 7, 77
24. Drake, P. M.; Schilling, B.; Niles, R. K.; Braten, M.; Johansen, E.; Liu, H.; Lerch, M.; Sorensen, D. J.; Li, B.; Allen, S.; Hall, S. C.; Witkowska, H. E.; Regnier, F. E.; Gibson, B. W.; Fisher, S. J. A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma Anal. Biochem. 2011, 408 (1) 71-85
25. Yingling, J. M.; Blanchard, K. L.; Sawyer, J. S. Development of TGF-beta signalling inhibitors for cancer therapy Nat. Rev. Drug Discovery 2004, 3 (12) 1011-22
26. Janatpour, M. J.; McMaster, M. T.; Genbacev, O.; Zhou, Y.; Dong, J.; Cross, J. C.; Israel, M. A.; Fisher, S. J. Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration Development 2000, 127 (3) 549-58
27. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2007, 6 (12) 2212-29
28. Shilov, I. V.; Seymour, S. L.; Patel, A. A.; Loboda, A.; Tang, W. H.; Keating, S. P.; Hunter, C. L.; Nuwaysir, L. M.; Schaeffer, D. A. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra Mol. Cell. Proteomics 2007, 6 (9) 1638-55
29. Krokhin, O. V.; Antonovici, M.; Ens, W.; Wilkins, J. A.; Standing, K. G. Deamidation of -Asn-Gly- sequences during sample preparation for proteomics: Consequences for MALDI and HPLC-MALDI analysis Anal. Chem. 2006, 78 (18) 6645-50
30. Link, A. J.; Eng, J.; Schieltz, D. M.; Carmack, E.; Mize, G. J.; Morris, D. R.; Garvik, B. M.; Yates, J. R., 3rd Direct analysis of protein complexes using mass spectrometry Nat. Biotechnol. 1999, 17 (7) 676-82
31. Edgington, E. S. Randomization tests, 3 rd ed.; Marcel-Dekker: New York, 1995.
32. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26 (7) 966-8
33. Griffith, M.; Griffith, O. L.; Mwenifumbo, J.; Goya, R.; Morrissy, A. S.; Morin, R. D.; Corbett, R.; Tang, M. J.; Hou, Y. C.; Pugh, T. J.; Robertson, G.; Chittaranjan, S.; Ally, A.; Asano, J. K.; Chan, S. Y.; Li, H. I.; McDonald, H.; Teague, K.; Zhao, Y.; Zeng, T.; Delaney, A.; Hirst, M.; Morin, G. B.; Jones, S. J.; Tai, I. T.; Marra, M. A. Alternative expression analysis by RNA sequencing Nat. Methods 2010, 7 (10) 843-7
34. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stat. Soc., Ser. B 1995, 57 (1) 289-300
35. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27 (7) 633-41
36. Tabb, D. L.; Vega-Montoto, L.; Rudnick, P. A.; Variyath, A. M.; Ham, A. J.; Bunk, D. M.; Kilpatrick, L. E.; Billheimer, D. D.; Blackman, R. K.; Cardasis, H. L.; Carr, S. A.; Clauser, K. R.; Jaffe, J. D.; Kowalski, K. A.; Neubert, T. A.; Regnier, F. E.; Schilling, B.; Tegeler, T. J.; Wang, M.; Wang, P.; Whiteaker, J. R.; Zimmerman, L. J.; Fisher, S. J.; Gibson, B. W.; Kinsinger, C. R.; Mesri, M.; Rodriguez, H.; Stein, S. E.; Tempst, P.; Paulovich, A. G.; Liebler, D. C.; Spiegelman, C. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry J. Proteome Res. 2010, 9 (2) 761-76
37. Wu, Z. S.; Wu, Q.; Yang, J. H.; Wang, H. Q.; Ding, X. D.; Yang, F.; Xu, X. C. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer Int. J. Cancer 2008, 122 (9) 2050-6
38. Wang, Y.; Ao, X.; Vuong, H.; Konanur, M.; Miller, F. R.; Goodison, S.; Lubman, D. M. Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach J. Proteome Res. 2008, 7 (10) 4313-25
39. Baricevic, I.; Masnikosa, R.; Lagundzin, D.; Golubovic, V.; Nedic, O. Alterations of insulin-like growth factor binding protein 3 (IGFBP-3) glycosylation in patients with breast tumours Clin. Biochem. 2010, 43 (9) 725-31
40. Bast, R. C., Jr.; Xu, F. J.; Yu, Y. H.; Barnhill, S.; Zhang, Z.; Mills, G. B. CA 125: the past and the future Int. J. Biol. Markers 1998, 13 (4) 179-87
41. Yin, B. W.; Lloyd, K. O. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16 J. Biol. Chem. 2001, 276 (29) 27371-5
42. Yu, H.; Mouw, J. K.; Weaver, V. M. Forcing form and function: biomechanical regulation of tumor evolution Trends Cell Biol. 2011, 21 (1) 47-56
43. Rowe, R. G.; Weiss, S. J. Navigating ECM barriers at the invasive front: the cancer cell-stroma interface Annu. Rev. Cell Dev. Biol. 2009, 25, 567-95
44. Viloria-Petit, A. M.; Wrana, J. L. The TGFbeta-Par6 polarity pathway: linking the Par complex to EMT and breast cancer progression Cell Cycle 2010, 9 (4) 623-4
45. Barcellos-Hoff, M. H.; Akhurst, R. J. Transforming growth factor-beta in breast cancer: too much, too late Breast Cancer Res. 2009, 11 (1) 202
46. Bergers, G.; Javaherian, K.; Lo, K. M.; Folkman, J.; Hanahan, D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 1999, 284 (5415) 808-12
47. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation Cell 2011, 144 (5) 646-74
48. Blows, F. M.; Driver, K. E.; Schmidt, M. K.; Broeks, A.; van Leeuwen, F. E.; Wesseling, J.; Cheang, M. C.; Gelmon, K.; Nielsen, T. O.; Blomqvist, C.; Heikkila, P.; Heikkinen, T.; Nevanlinna, H.; Akslen, L. A.; Begin, L. R.; Foulkes, W. D.; Couch, F. J.; Wang, X.; Cafourek, V.; Olson, J. E.; Baglietto, L.; Giles, G. G.; Severi, G.; McLean, C. A.; Southey, M. C.; Rakha, E.; Green, A. R.; Ellis, I. O.; Sherman, M. E.; Lissowska, J.; Anderson, W. F.; Cox, A.; Cross, S. S.; Reed, M. W.; Provenzano, E.; Dawson, S. J.; Dunning, A. M.; Humphreys, M.; Easton, D. F.; Garcia-Closas, M.; Caldas, C.; Pharoah, P. D. Huntsman, D., Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies PLoS Med. 2010, 7 (5) e1000279
49. Hortin, G. L.; Sviridov, D.; Anderson, N. L. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance Clin. Chem. 2008, 54 (10) 1608-16
50. Farrah, T.; Deutsch, E. W.; Omenn, G. S.; Campbell, D. S.; Sun, Z.; Bletz, J. A.; Mallick, P.; Katz, J. E.; Malmstrom, J.; Ossola, R.; Watts, J. D.; Lin, B.; Zhang, H.; Moritz, R. L.; Aebersold, R. H. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas Mol. Cell. Proteomics 2011, 10 (9, Sep) M110.006353
51. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24 (8) 971-83
52. Lengyel, E. Ovarian cancer development and metastasis Am. J. Pathol. 2010, 177 (3) 1053-64
53. Vang, R.; Shih, Ie, M.; Kurman, R. J. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Adv. Anat. Pathol. 2009, 16 (5) 267-82
54. Ahn, Y.; Kang, U. B.; Kim, J.; Lee, C. Mining of serum glycoproteins by an indirect approach using cell line secretome Mol. Cells 2010, 29 (2) 123-30
55. Arcinas, A.; Yen, T. Y.; Kebebew, E.; Macher, B. A. Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns J. Proteome Res. 2009, 8 (8) 3958-68
56. Rangiah, K.; Tippornwong, M.; Sangar, V.; Austin, D.; Tetreault, M. P.; Rustgi, A. K.; Blair, I. A.; Yu, K. H. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer J. Proteome Res. 2009, 8 (11) 5153-64
57. Sardana, G.; Jung, K.; Stephan, C.; Diamandis, E. P. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers J. Proteome Res. 2008, 7 (8) 3329-38
58. Akasaka-Manya, K.; Manya, H.; Sakurai, Y.; Wojczyk, B. S.; Spitalnik, S. L.; Endo, T. Increased bisecting and core-fucosylated N-glycans on mutant human amyloid precursor proteins Glycoconj. J. 2008, 25 (8) 775-86
59. Nakagawa, K.; Kitazume, S.; Oka, R.; Maruyama, K.; Saido, T. C.; Sato, Y.; Endo, T.; Hashimoto, Y. Sialylation enhances the secretion of neurotoxic amyloid-beta peptides J. Neurochem. 2006, 96 (4) 924-33
60. Garrigue-Antar, L.; Hartigan, N.; Kadler, K. E. Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein J. Biol. Chem. 2002, 277 (45) 43327-34
61. Wolf, B. Biotinidase Deficiency: New Directions and Practical Concerns Curr. Treat. Options Neurol. 2003, 5 (4) 321-28
62. Ciolczyk-Wierzbicka, D.; Amoresano, A.; Casbarra, A.; Hoja-Lukowicz, D.; Litynska, A.; Laidler, P. The structure of the oligosaccharides of N-cadherin from human melanoma cell lines Glycoconj. J. 2004, 20 (7-8) 483-92
63. Takahashi, T.; Schmidt, P. G.; Tang, J. Novel carbohydrate structures of cathepsin B from porcine spleen J. Biol. Chem. 1984, 259 (10) 6059-62
64. Dimitroff, C. J.; Lee, J. Y.; Rafii, S.; Fuhlbrigge, R. C.; Sackstein, R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells J. Cell Biol. 2001, 153 (6) 1277-86
65. Elliott, M. M.; Kardana, A.; Lustbader, J. W.; Cole, L. A. Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma Endocrine 1997, 7 (1) 15-32
66. Kapron, J. T.; Hilliard, G. M.; Lakins, J. N.; Tenniswood, M. P.; West, K. A.; Carr, S. A.; Crabb, J. W. Identification and characterization of glycosylation sites in human serum clusterin Protein Sci. 1997, 6 (10) 2120-33
67. Goldberg, M.; Peshkovsky, C.; Shifteh, A.; Al-Awqati, Q. mu-Protocadherin, a novel developmentally regulated protocadherin with mucin-like domains J. Biol. Chem. 2000, 275 (32) 24622-9
68. Hirnle, L.; Katnik-Prastowska, I. Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection Clin. Chem. Lab. Med. 2007, 45 (2) 208-14
69. Miyamae, T.; Marinov, A. D.; Sowders, D.; Wilson, D. C.; Devlin, J.; Boudreau, R.; Robbins, P.; Hirsch, R. Follistatin-like protein-1 is a novel proinflammatory molecule J. Immunol. 2006, 177 (7) 4758-62
70. Hyuga, M.; Itoh, S.; Kawasaki, N.; Ohta, M.; Ishii, A.; Hyuga, S.; Hayakawa, T. Analysis of site-specific glycosylation in recombinant human follistatin expressed in Chinese hamster ovary cells Biologicals 2004, 32 (2) 70-7
71. Ohgomori, T.; Funatsu, O.; Nakaya, S.; Morita, A.; Ikekita, M. Structural study of the N-glycans of intercellular adhesion molecule-5 (telencephalin) Biochim. Biophys. Acta 2009, 1790 (12) 1611-23
72. Pochec, E.; Litynska, A.; Amoresano, A.; Casbarra, A. Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression Biochim. Biophys. Acta 2003, 1643 (1-3) 113-23
73. Newburg, D. S.; Peterson, J. A.; Ruiz-Palacios, G. M.; Matson, D. O.; Morrow, A. L.; Shults, J.; Guerrero, M. L.; Chaturvedi, P.; Newburg, S. O.; Scallan, C. D.; Taylor, M. R.; Ceriani, R. L.; Pickering, L. K. Role of human-milk lactadherin in protection against symptomatic rotavirus infection Lancet 1998, 351 (9110) 1160-4
74. Stimson, E.; Hope, J.; Chong, A.; Burlingame, A. L. Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions Biochemistry 1999, 38 (15) 4885-95
75. Sato, S.; Rahemtulla, F.; Prince, C. W.; Tomana, M.; Butler, W. T. Acidic glycoproteins from bovine compact bone Connect. Tissue Res. 1985, 14 (1) 51-64
76. Nakahara, Y.; Miyata, T.; Hamuro, T.; Funatsu, A.; Miyagi, M.; Tsunasawa, S.; Kato, H. Amino acid sequence and carbohydrate structure of a recombinant human tissue factor pathway inhibitor expressed in Chinese hamster ovary cells: one N-and two O-linked carbohydrate chains are located between Kunitz domains 2 and 3 and one N-linked carbohydrate chain is in Kunitz domain 2 Biochemistry 1996, 35 (20) 6450-9
77. Brunner, A. M.; Gentry, L. E.; Cooper, J. A.; Purchio, A. F. Recombinant type 1 transforming growth factor beta precursor produced in Chinese hamster ovary cells is glycosylated and phosphorylated Mol. Cell. Biol. 1988, 8 (5) 2229-32
78. Ploug, M.; Rahbek-Nielsen, H.; Nielsen, P. F.; Roepstorff, P.; Dano, K. Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells J. Biol. Chem. 1998, 273 (22) 13933-43